Inventor
CHAN-HUI PO-YING
US27 patents
⚠️ This page may combine multiple inventors who share the name “CHAN-HUI PO-YING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERACLONE SCIENCES INC
12 patentsUS10087239B2Oct 2, 2018
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC14 citations91
US9464131B2Oct 11, 2016
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC18 citations91
US11319362B2May 3, 2022
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
THERACLONE SCIENCES INC3 citations83
US10865234B2Dec 15, 2020
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC1 citations72
US10836811B2Nov 17, 2020
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC1 citations72
US10407493B2Sep 10, 2019
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC1 citations72
US12312396B2May 27, 2025
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US12018067B2Jun 25, 2024
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US11584789B2Feb 21, 2023
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US11845789B2Dec 19, 2023
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
THERACLONE SCIENCES INC0 citations61
US10239934B2Mar 26, 2019
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations51
US9920111B2Mar 20, 2018
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations51
MONOGRAM BIOSCIENCES INC
7 patentsUS7402399B2Jul 22, 2008
Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
MONOGRAM BIOSCIENCES INC75 citations95
US7105308B2Sep 12, 2006
Detecting receptor oligomerization
MONOGRAM BIOSCIENCES INC55 citations95
US7402398B2Jul 22, 2008
Measuring receptor homodimerization
MONOGRAM BIOSCIENCES INC27 citations92
US7135300B2Nov 14, 2006
Profiling frequencies of receptor heterodimers
MONOGRAM BIOSCIENCES INC34 citations92
US7122319B2Oct 17, 2006
Multiplexed immunohistochemical assays using molecular tags
MONOGRAM BIOSCIENCES INC30 citations92
US7648828B2Jan 19, 2010
Methods for detecting receptor complexes comprising PI3K
MONOGRAM BIOSCIENCES INC34 citations91
US7402397B2Jul 22, 2008
Detecting and profiling molecular complexes
MONOGRAM BIOSCIENCES INC40 citations89
CHAN-HUI PO-YING
4 patentsUS9051362B2Jun 9, 2015
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
CHAN-HUI PO-YING14 citations91
US8609101B2Dec 17, 2013
Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies
CHAN-HUI PO-YING3 citations60
USRE44437EAug 13, 2013
Methods for detecting receptor complexes comprising PI3K
CHAN-HUI PO-YING2 citations60
US8822651B2Sep 2, 2014
Human rhinovirus (HRV) antibodies
CHAN-HUI PO-YING0 citations40